284 related articles for article (PubMed ID: 24670570)
1. Isoniazid preventive therapy in HIV-infected children on antiretroviral therapy: a pilot study.
Gray DM; Workman LJ; Lombard CJ; Jennings T; Innes S; Grobbelaar CJ; Cotton MF; Zar HJ
Int J Tuberc Lung Dis; 2014 Mar; 18(3):322-7. PubMed ID: 24670570
[TBL] [Abstract][Full Text] [Related]
2. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.
Gray DM; Zar H; Cotton M
Cochrane Database Syst Rev; 2009 Jan; (1):CD006418. PubMed ID: 19160285
[TBL] [Abstract][Full Text] [Related]
3. The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting.
Frigati LJ; Kranzer K; Cotton MF; Schaaf HS; Lombard CJ; Zar HJ
Thorax; 2011 Jun; 66(6):496-501. PubMed ID: 21460373
[TBL] [Abstract][Full Text] [Related]
4. Isoniazid for preventing tuberculosis in HIV-infected children.
Zunza M; Gray DM; Young T; Cotton M; Zar HJ
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD006418. PubMed ID: 28850172
[TBL] [Abstract][Full Text] [Related]
5. Randomised controlled trial of isoniazid preventive therapy in South African adults with advanced HIV disease.
Mohammed A; Myer L; Ehrlich R; Wood R; Cilliers F; Maartens G
Int J Tuberc Lung Dis; 2007 Oct; 11(10):1114-20. PubMed ID: 17945069
[TBL] [Abstract][Full Text] [Related]
6. Isoniazid preventive therapy and 4-year incidence of pulmonary tuberculosis among HIV-infected Thai patients.
Khawcharoenporn T; Apisarnthanarak A; Manosuthi W; Sungkanuparph S; Mundy LM
Int J Tuberc Lung Dis; 2012; 16(3):336-41. PubMed ID: 22230143
[TBL] [Abstract][Full Text] [Related]
7. Isoniazid preventive therapy use among patients on antiretroviral therapy: a missed opportunity.
Kufa T; Chihota VN; Charalambous S; Churchyard GJ
Int J Tuberc Lung Dis; 2014 Mar; 18(3):312-4. PubMed ID: 24670568
[TBL] [Abstract][Full Text] [Related]
8. Implementation of isoniazid preventive therapy in an HIV clinic in Cambodia: high rates of discontinuation when combined with antiretroviral therapy.
van Griensven J; Choun K; Chim B; Thai S; Lorent N; Lynen L
Trop Med Int Health; 2015 Dec; 20(12):1823-31. PubMed ID: 26426387
[TBL] [Abstract][Full Text] [Related]
9. Anti-tuberculosis treatment outcomes in HIV-infected adults exposed to isoniazid preventive therapy in Botswana.
Sibanda T; Tedla Z; Nyirenda S; Agizew T; Marape M; Miranda AG; Reuter H; Johnson JL; Samandari T
Int J Tuberc Lung Dis; 2013 Feb; 17(2):178-85. PubMed ID: 23317952
[TBL] [Abstract][Full Text] [Related]
10. Source case identification in HIV-exposed infants and tuberculosis diagnosis in an isoniazid prevention study.
Maritz ER; Montepiedra G; Liu L; Mitchell CD; Madhi SA; Bobat R; Violari A; Ogwu A; Hesseling AC; Cotton MF
Int J Tuberc Lung Dis; 2016 Aug; 20(8):1060-4. PubMed ID: 27393540
[TBL] [Abstract][Full Text] [Related]
11. Safety of long-term isoniazid preventive therapy in children with HIV: a comparison of two dosing schedules.
le Roux SM; Cotton MF; Myer L; le Roux DM; Schaaf HS; Lombard CJ; Zar HJ
Int J Tuberc Lung Dis; 2013 Jan; 17(1):26-31. PubMed ID: 23146410
[TBL] [Abstract][Full Text] [Related]
12. Low rates of hepatotoxicity in HIV-infected children on anti-retroviral therapy with and without isoniazid prophylaxis.
Gray D; Nuttall J; Lombard C; Davies MA; Workman L; Apolles P; Eley B; Cotton M; Zar HJ
J Trop Pediatr; 2010 Jun; 56(3):159-65. PubMed ID: 19710246
[TBL] [Abstract][Full Text] [Related]
13. Isoniazid-associated hepatitis and antiretroviral drugs during tuberculosis prophylaxis in hiv-infected adults in Botswana.
Tedla Z; Nyirenda S; Peeler C; Agizew T; Sibanda T; Motsamai O; Vernon A; Wells CD; Samandari T
Am J Respir Crit Care Med; 2010 Jul; 182(2):278-85. PubMed ID: 20378730
[TBL] [Abstract][Full Text] [Related]
14. The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.
Seddon JA; Hesseling AC; Marais BJ; Jordaan A; Victor T; Schaaf HS
Int J Tuberc Lung Dis; 2012 Jul; 16(7):928-33. PubMed ID: 22583610
[TBL] [Abstract][Full Text] [Related]
15. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
Rose PC; Hallbauer UM; Seddon JA; Hesseling AC; Schaaf HS
Int J Tuberc Lung Dis; 2012 Dec; 16(12):1588-93. PubMed ID: 23032215
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of peripheral neuropathy in antiretroviral therapy naïve HIV-positive patients and the impact on treatment outcomes--a retrospective study from a large urban cohort in Johannesburg, South Africa.
Evans D; Takuva S; Rassool M; Firnhaber C; Maskew M
J Neurovirol; 2012 Jun; 18(3):162-71. PubMed ID: 22528477
[TBL] [Abstract][Full Text] [Related]
17. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.
Gao XF; Wang L; Liu GJ; Wen J; Sun X; Xie Y; Li YP
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1080-90. PubMed ID: 17044199
[TBL] [Abstract][Full Text] [Related]
18. Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa.
Szakacs TA; Wilson D; Cameron DW; Clark M; Kocheleff P; Muller FJ; McCarthy AE
BMC Infect Dis; 2006 Jun; 6():97. PubMed ID: 16772037
[TBL] [Abstract][Full Text] [Related]
19. Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania.
Hunter OF; Kyesi F; Ahluwalia AK; Daffé ZN; Munseri P; von Reyn CF; Adams LV
BMC Infect Dis; 2020 Oct; 20(1):738. PubMed ID: 33028260
[TBL] [Abstract][Full Text] [Related]
20. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
